Hamstrings Graft Donor Site Infiltration with Bupivacaine for Pain Relief after Arthroscopically Assisted Anterior Cruciate Ligament Reconstruction - Hamstrings graft donor site pain relief after ACL reconstructio
Phase 1
- Conditions
- Anterior Cruciate Ligament Reconstruction
- Registration Number
- EUCTR2006-001556-12-GB
- Lead Sponsor
- Derby Hospitals NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients having primary anterior cruciate ligament reconstruction with ipsilateral hamstrings tendon graft, under spinal anaesthesia
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients unwilling to participate in the trial
Those undergoing any procedure other than that detailed above
Patients unable to consent for themselves
Patients with known allergy to Bupivacaine
Patients with peripheral neuropathy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To determine if hamstring graft donor site infiltration with local anaesthetic plus femoral nerve block provides better pain relief than femoral nerve block alone in patients having ipsilateral hamstrings tendon anterior curciate ligament reconstruction.;Secondary Objective: ;Primary end point(s): Pain relief in the region of the hamstrings during the first 24 hours post-operatively
- Secondary Outcome Measures
Name Time Method